BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17489989)

  • 1. Retiform purpura in plaques: a morphological approach to diagnosis.
    Jones A; Walling H
    Clin Exp Dermatol; 2007 Sep; 32(5):596-602. PubMed ID: 17489989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to the patient with retiform purpura.
    Wysong A; Venkatesan P
    Dermatol Ther; 2011; 24(2):151-72. PubMed ID: 21410606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatopathology of skin necrosis associated with purpura fulminans.
    Adcock DM; Hicks MJ
    Semin Thromb Hemost; 1990 Oct; 16(4):283-92. PubMed ID: 2281318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigmented purpura and cutaneous vascular occlusion syndromes.
    Lamadrid-Zertuche AC; Garza-Rodríguez V; Ocampo-Candiani JJ
    An Bras Dermatol; 2018 Jun; 93(3):397-404. PubMed ID: 29924250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole.
    Walsh NM; Green PJ; Burlingame RW; Pasternak S; Hanly JG
    J Cutan Pathol; 2010 Dec; 37(12):1212-9. PubMed ID: 20738457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of livedoid vasculopathy in a 22-year-old man.
    Leonard A; Pomeranz MK; Franks AG
    J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis in catastrophic antiphospholipid antibody syndrome.
    Shah S; Larson A; Datta Y
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):467-8. PubMed ID: 25688465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retiform purpura: Workup and therapeutic considerations in select conditions.
    Georgesen C; Fox LP; Harp J
    J Am Acad Dermatol; 2020 Apr; 82(4):799-816. PubMed ID: 31479690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations of antiphospholipid antibody syndrome.
    Weinstein S; Piette W
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous calciphylaxis. An underrecognized clinicopathologic entity.
    Essary LR; Wick MR
    Am J Clin Pathol; 2000 Feb; 113(2):280-7. PubMed ID: 10664631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous manifestations of disseminated intravascular coagulation syndrome. Apropos of 7 cases].
    Torres Cortijo A; Man A; Ferradas R
    Med Cutan Ibero Lat Am; 1984; 12(2):99-105. PubMed ID: 6374331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma.
    Grenier N; Chen-Tsai C
    Int J Low Extrem Wounds; 2006 Sep; 5(3):200-3. PubMed ID: 16928675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the hospital dermatologist in the diagnosis and treatment of calciphylaxis and nephrogenic systemic fibrosis.
    Weenig RH; Gibson LE; el-Azhary R
    Semin Cutan Med Surg; 2007 Sep; 26(3):163-7. PubMed ID: 18070683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum-like changes.
    Lewis KG; Lester BW; Pan TD; Robinson-Bostom L
    J Cutan Pathol; 2006 Oct; 33(10):695-700. PubMed ID: 17026522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical ischemic lower extremity ulcerations: a differential diagnosis.
    Dean SM
    Vasc Med; 2008 Feb; 13(1):47-54. PubMed ID: 18372440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palpable purpura: an algorithmic approach.
    Stevens GL; Adelman HM; Wallach PM
    Am Fam Physician; 1995 Oct; 52(5):1355-62. PubMed ID: 7572558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factitious purpura in a 10-year-old girl.
    Yamada K; Sakurai Y; Shibata M; Miyagawa S; Yoshioka A
    Pediatr Dermatol; 2009; 26(5):597-600. PubMed ID: 19840319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous thrombotic vasculopathy syndrome: an ominous condition reminiscent of calciphylaxis: calciphylaxis sine calcifications?
    Zembowicz A; Navarro P; Walters S; Lyle SR; Moschella SL; Miller D
    Am J Dermatopathol; 2011 Dec; 33(8):796-802. PubMed ID: 21785327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cutaneous manifestation of antiphospholipid antibody syndrome.
    DiFrancesco LM; Burkart P; Hoehn JG
    Ann Plast Surg; 2003 Nov; 51(5):517-22. PubMed ID: 14595191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis.
    Adcock DM; Brozna J; Marlar RA
    Semin Thromb Hemost; 1990 Oct; 16(4):333-40. PubMed ID: 2281322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.